Next Article in Journal
Secondary Hyperparathyroidism and Hypertension: An Intriguing Couple
Next Article in Special Issue
Assessment of Physical Activity Patterns in Adolescent Patients with Anorexia Nervosa and Their Effect on Weight Gain
Previous Article in Journal
Serum Catestatin Levels and Arterial Stiffness Parameters Are Increased in Patients with Inflammatory Bowel Disease
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 9
Issue 3
10.3390/jcm9030630
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cognitive Interpersonal Model for Anorexia Nervosa Revisited: The Perpetuating Factors that Contribute to the Development of the Severe and Enduring Illness

by
Janet Treasure
1,†,
Daniel Willmott
1,*,†,
Suman Ambwani
2,
Valentina Cardi
1,
Danielle Clark Bryan
1,
Katie Rowlands
1 and
Ulrike Schmidt
1
1
Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, SE5 8AF London, UK
2
Department of Psychology, Dickinson College, Carlisle, PA17013, USA
*
Author to whom correspondence should be addressed.
†
These authors equally contributed to this work.
J. Clin. Med. 2020, 9(3), 630; https://doi.org/10.3390/jcm9030630
Submission received: 30 January 2020 / Revised: 21 February 2020 / Accepted: 25 February 2020 / Published: 27 February 2020
(This article belongs to the Special Issue Advances in Eating Disorders)
Browse Figures
Versions Notes

Abstract

:
The cognitive interpersonal model was outlined initially in 2006 in a paper describing the valued and visible aspects of anorexia nervosa (Schmidt and Treasure, 2006). In 2013, we summarised many of the cognitive and emotional traits underpinning the model (Treasure and Schmidt, 2013). In this paper, we describe in more detail the perpetuating aspects of the model, which include the inter- and intrapersonal related consequences of isolation, depression, and chronic stress that accumulate in the severe and enduring stage of the illness. Since we developed the model, we have been using it to frame research and development at the Maudsley. We have developed and tested interventions for both patients and close others, refining the model through iterative cycles of model/intervention development in line with the Medical Research Council (MRC) framework for complex interventions. For example, we have defined the consequences of living with the illness on close others (including medical professionals) and characterised the intense emotional reactions and behaviours that follow. For the individual with an eating disorder, these counter-reactions can allow the eating disorder to become entrenched. In addition, the consequent chronic stress from starvation and social pain set in motion processes such as depression, neuroprogression, and neuroadaptation. Thus, anorexia nervosa develops a life of its own that is resistant to treatment. In this paper, we describe the underpinnings of the model and how this can be targeted into treatment.

1. Introduction

The Medical Research Council has described a framework for the process of development of complex interventions [1]. This involves a procedure in which treatments targeting risk or maintaining factors for an illness are fine-tuned following feedback from proof of concept, feasibility, and pilot studies, including both quantitative and qualitative outcomes. Furthermore, within UK health care research conducted in the National Health Service (NHS), a strong emphasis is placed upon the involvement of patients, carers, and the public to co-design interventions and services. We have used this combined approach to design interventions and services for people with anorexia nervosa (AN).
The first iteration of the cognitive interpersonal model for AN outlined core valued and visible maintaining factors of the illness (Figure 1) [2]; the visible aspects of the disorder elicit deep concern from close others, which is in stark contrast to the egosyntonic nature of the illness, where the sufferer values certain aspects of the illness and does not identify themselves as ‘sick’. In the next iteration of the model, we outlined the underpinning neuroscience, the interaction between vulnerability traits and eating disorder behaviours, and how this serves to strengthen the hold of the disorder, allowing it over time to develop a life of its own [3]. Indeed, individuals with a persistent form of the illness often state that they want to change but cannot do so. Examples of interactions between vulnerability traits and eating disorder behaviours include personality traits such as conscientiousness and introversion [4], which can predispose to disordered eating [5] and allow eating disorder habits to become fixed. Furthermore, recent genetic findings reported on correlations between polygenic risk scores, not only with other “brain” disorders, but also with “metabolic” traits related to growth, size, lipids, and insulin sensitivity [6]. Thus, a possible hypothesis is that homeostatic forces maintaining energy balance might be weaker in terms of increasing appetite and stronger in terms of a foraging or over active response to “food shortage”. This argument has been developed in more detail in an evolutionary-based model of AN and might benefit from further exploration [7].

2. Staging Models of Anorexia Nervosa: the Enhanced Cognitive Interpersonal Maintenance Model

This next iteration of the model describes in more detail the development of the severe and enduring form of AN [8]. Current diagnostic procedures do not account for clinical features such as illness trajectory, severity, and co-morbidity, which may impact on the effectiveness of current treatments. The maintenance model of severe and enduring AN consists of three components (Figure 2). The first domain includes the interpersonal consequences of AN. These arise in part because of the impact of chronic starvation on social cognition and the reaction of others to the illness. The next domain relates to the behavioural consequences of AN. Neuroadaptation and habits develop as a consequence of repeated behaviours. Moreover, feeding experiences can increase aversive learning towards food. The third domain relates to the chronic stress response, which may relate to a genetic predisposition to susceptibility, early adversity, or be a secondary response to chronic starvation.
In this paper, we consider in more depth these three domains that contribute to the development of the severe enduring form of illness.

3. Social Risk and Maintaining Factors

Difficulties with interpersonal relationships predispose to the development of AN and are also secondary consequences of the disorder, contributing to the perseverance of the illness.
Social anxiety is a common precursor of eating disorders [9]. In some cases, this is part of the autistic spectrum profile of symptoms that has been observed [10,11], and problems with social cognition may form part of the genetic liability. For example, the offspring of mothers with a history of an eating disorder had anomalies in social cognition during childhood [12]. This familial association suggests that problems in social cognition may be an endophenotype that increases the risk of developing an ED. In addition, adverse social experiences during development such as childhood maltreatment [13], insecure attachment [14], or teasing, bullying, or social exclusion [15] can shape interpersonal relationships and disrupt normal identity development, potentially by increasing the salience of competitive patterns of interaction that can fuel striving for perfection and greater internalisation of beauty ideals as a standard to define the self [16].
Furthermore, people with AN are more likely to report early maladaptive schema (pervasive negative themes regarding the self and one’s relationship with others [17]) and difficulties in emotion regulation, with a greater use of dysfunctional interpersonal emotion regulation strategies [18,19]. Problems in emotion regulation may play a key role in maintaining the symptoms of AN [20]. Thus, an interaction between social vulnerability traits, risks within the interpersonal environment, and dysfunctional emotion processing can predispose to the development of AN, a “social–emotional disorder” [21].
Problems in social cognition also can arise as secondary consequences of starvation. Anomalies in social cognition are most pronounced in the acute phase of illness and are less marked after recovery [22]. The anomalies include deficits in nonverbal emotional expression [23,24], an inability to provide a spontaneous social narrative and to identify the social salience of stimuli [25], a sensitivity to threat [26], to social comparison [27], misalignments in social reciprocity [28], and the avoidance or suppression of emotions, particularly to avoid conflict [19]. Impairments in nonverbal communication and a lack of reciprocation of warmth elicits the “uncanny valley” aversive response in others [29,30,31]. This can lead to social exclusion and isolation, which is a defining facet of the illness [32].

3.1. Interpersonal Reactions to Living with Anorexia Nervosa

A mental health professional with lived experience of AN used one word to epitomize the illness: “isolation” [32]. However, family members are usually closely involved in the evolution of AN, which commonly has its onset in early adolescence. Close others can encourage help seeking in the early phase of the illness, which in turn may have a favourable effect on the prognosis. Nevertheless, the individual’s resistance to the need for treatment can make negotiating this transition difficult. The disruption of family functioning, work, and social adjustment varies accordingly with the developmental age, mood, and other clinical features. Many patients with a chronic form of illness remain dependent on their families or the state during their lifetime [33].
The anxiety engendered by the overt “ill state” and the frustration caused by the resistance to implement the obvious solution “to eat” fuels a profound and mixed emotional reaction in both professionals (nurses on inpatient units) [34] and families [35]. Lack of insight into the illness is particularly pronounced in restrictive AN and persists during and after treatment [36,37]. Critical, hostile, overprotective, and controlling behaviours can develop as counter reactions [38,39]. Family members may appease and collude with eating disorder behaviours, becoming organised around eating disorder rules (accommodating to the illness) and ignoring or covering up for the negative consequences of the behaviours (inadvertently enabling the illness) [40].
These diverse reactions can cause divisions amongst family members. Some family members shoulder an overly high burden, whilst others become disempowered and disengaged. Aspects of the caregiving experience are summarised in systematic reviews [35]. High perceived burden and low caregiving efficacy are common and are associated with clinical levels of depression and anxiety. In addition, the societal reaction to the illness (including interactions with services) can be problematic.
Carers’ own practical and emotional reactions to the illness can cause harm to the family unit as relationship ruptures occur in response to accommodating and enabling behaviours [41] or divergent forms of reactive expressed emotion develop. Siblings can be drawn into caregiving, develop their own problems, or leave home prematurely as their needs may be neglected [42,43]. Thus, a vicious circle of escalating interpersonal stress can develop.
The protracted course of the illness and the entanglement between eating and social function means that close others have the potential to remediate these difficulties. Therefore, it is important that carers and close others are involved across the lifespan and not excluded from the treatment process. Clinicians explain this exclusion through concerns around confidentiality, but this is considered a misinterpretation of the law [44].

3.2. Targeting Stressful Interpersonal Reactions

A hypothesis that follows from the cognitive interpersonal model is that the toxic consequences that accrue from the isolation and loneliness of an eating disorder can be ameliorated by skills training for family members or close others across the lifespan [45]. Improving the interpersonal environment often begins at home. Close others are highly motivated to help but are often uncertain of what they can do. Materials coproduced with carers and patients have been developed to illustrate these problems [39] and provide a curriculum for workshops to help carers provide effective support.
These materials explain how the patients’ primary and secondary difficulties in social cognition make relationships difficult. For example, the reduced facial expressivity of eating disorder patients [23,24] makes it hard for others to appreciate their level of terror or show appreciation of the carers’ distress. AN patients appear to be impervious to the impact of their behaviours on other people. This lack of concern for others appears in the domain of caregiving when others are distressed at their lack of insight and unwillingness to accept the sick role. It also can be evident in treatment facilities where overt demonstration and discussion of eating disorder behaviours can trigger distress in their peers.
The three basic elements of carer skill-sharing interventions include:
(1) Psychoeducation about the illness and framing patient presentation within the cognitive–interpersonal model, highlighting predisposing, precipitating, and perpetuating factors.
(2) Information about how carers might be able to moderate and mould the energy and insight from their own emotional reactions to foster a calm, compassionate, and collaborative context (a life skill that they can role model to the person with the eating disorder).
(3) Introduction to effective support and behaviour change skills such as motivational interviewing, the use of risk-taking experiments, and exposure to fear [46].
Interventions based on this model have been delivered in a range of different formats including workshops and guided self-help interventions with individual or group support. An improved understanding about the illness reduces carer distress and burden [35,45,47,48]. Several studies have found that augmenting treatment with these resources for carers reduces both carer and service burden [49,50,51]. Often this has involved a ‘train the trainer’ approach whereby carers and patients deliver these interventions. Pépin and King [52] tested the workshops in a pilot study in Australia, finding participation led to reductions in carer distress and burden and helped them to modify their emotional reactions to the illness. Psychoeducational carer workshops reduce carer psychological distress and burden, yet when collaborative carer skills are taught as well, there are secondary effects on alleviating patients’ anxiety and depression [53].
Treatment for individuals with AN based on the cognitive interpersonal model, the Maudsley Model of Anorexia Treatment for Adults (MANTRA) [54,55], also includes a section for carers. Carers are encouraged to cultivate their own emotional and social intelligence by examining the relevant modules for patients so that they can role model these skills to their loved ones. It is helpful if both parties externalise the illness and understand how the AN voice can trap everyone into spirals of confusion. A compassionate, mutually supportive family environment is essential as it is inevitable that miscues and mistakes will happen, but these can be reframed as being valuable opportunities of learning.

4. Behavioural Consequences of Anorexia Nervosa

The repeated patterns of behaviour that underpin the development of AN, such as avoiding high caloric, highly palatable foods, becomes habitual. Initially, these behaviours are initiated to achieve a specific goal and are reinforced as they are positively rewarding. With daily repetition, the actions become automatic and entrenched until they are activated with no conscious effort in response to a stimulus or cue [56]. A recent cognitive neuroscience model of AN proposes that habitual behaviours are mediated within dorsal frontostriatal circuits [57,58,59]. In line with this, techniques from habit reversal therapy with inpatients led to significant reductions in eating disorder symptoms and self-reported habit strengths [60]. These preliminary findings could be used to augment or guide developments in treatment for those with severe and enduring difficulties.
In addition, fear and/or disgust responses to food represents a key challenge to weight restoration [61]. People with AN show reduced extinction of fear learning but increased fear generalisation and reinstatement, which may contribute to the strength of these fear learning networks [62]. These fears may originate from adverse experiences relating to food and body shape during sensitive periods of development [63]. Furthermore, these could be iatrogenically aggravated by coercive treatment experiences such as nasogastric feeding under restraint. A qualitative study with nurses identified that power battles over ‘punitive’ feeding causes patients great anguish and can rupture the therapeutic alliance [64]. These interactions may be overlooked as a complicating feature within family-based treatment [65]. Interestingly, in adolescence, reduced extinction of fears appears to be more pronounced with co-morbid depression [66].
Exposure is the standard treatment for fear learning. The underlying mechanism involves developing new learning to the threatening stimulus (as opposed to habituation to anxiety) and updating the fear pathways in the brain [67,68]. There are some caveats in applying this treatment to AN. First, one of the feared consequences, weight gain, is an expected and necessary consequence of refeeding. Furthermore, with fluid fluxes and other aspects of metabolic instability during this phase, a “lack of control of weight” can maintain AN cognitions. Moreover, it is probable that neurogenesis is reduced as a sequelae of the chronic stress of AN, reducing the effectiveness of exposure. A variety of techniques have been used to facilitate this learning. These include positive mood induction [69], the addition of cycloserine to consolidate learning [70,71], and virtual reality [72].
Other training approaches developed to target risk factors show some promise in proof-of-concept studies. These include cognitive remediation approaches that focus on cultivating a flexible, big picture style of thinking [73], cognitive skills training for social avoidance [74], and go/no-go inhibition training [75], which may be of value for the binge–purge form of the illness. Food-related attention bias modification training is also being investigated as an add-on intervention for AN, following directions from anxiety disorder research [76,77].

5. Chronic Stress Response: Co-Morbidity with Depression and Anxiety

Another maintaining factor in the model is the impact of chronic starvation leading to anhedonia and accentuating existing co-morbidities. Emotional distress is common as both a predisposition and a secondary consequence that perpetuates the illness [20,78,79]. This emotional distress may occur due to a shared genetic predisposition [6]; developmental trauma [80], with emotional abuse (e.g., bullying) playing a central role [81]; or as a feature of starvation [82].
Depressive symptomatology may follow a persistent trajectory over the lifetime, independently from eating disorder symptoms [83,84]. Approximately 50% of patients with AN report a minimum of one episode of a mood disorder during their lifetime [85,86]. Depression, anxiety, and interpersonal sensitivity are central nodes in a network analysis of symptoms [87] with key bridging roles [81]. The symptom profile differs somewhat from that of unipolar depression in that somatic features such as loss of energy and reduced activation are less pronounced, whereas cognitive features such as negative views of the self are higher [88]. Indeed, the chance of recovery is reduced in people who developed AN after they had experienced depression [89]. In addition, the long-term outcomes of patients with AN complicated with mood comorbidity were reduced [90]. Consequently, psychological well-being, positive supportive relationships, hope, identity, meaning, and purpose are important markers of recovery [91,92].
Anxiety traits are also linked to eating disorders. Obsessive–compulsive personality traits, obsessive–compulsive disorders, and anxiety [9,93,94] often present in childhood prior to the onset of AN. In addition, there is a strong familial association with these traits [95,96]. The strongest polygenic risk correlations from genome wide association studies (GWAS) of AN is shared with OCD [97], whereas correlations with neuroticism, depression, and anxiety are half the size [6]. In a network analysis of eating disorder and anxiety traits, avoidance of social eating was the strongest bridge node, with eating symptoms and low self-confidence being the strongest bridge node with anxiety traits [98].
In a longitudinal study, the neural correlates of disordered eating and obsessive–compulsive disorder at age 14 included an increase in grey matter volume in the orbitofrontal cortex, the right dorsolateral prefrontal cortex, and the ventral striatum [99]. However, people with a chronic illness had a decrease in grey matter in the cerebellum and the mesencephalon, specifically the substantia nigra and ventral tegmental area [100]. Hippocampal volume is particularly reduced [101,102,103] which is associated with anxiety and depression [102] and correlated with raised cortisol [104]. Patients in the later stage of AN have increased ventral striatal activation to body image cues than patients in the early stage of illness [105,106].
The chronic stress profile associated with enduring AN [107] is similar to that found in treatment resistant depression [108] and with the ‘ecophenotype’ associated with childhood maltreatment [109]. This chronic stress response includes hyperactivity of the hypothalamic pituitary adrenal (HPA) axis [101,110,111,112], activation of the immune system [113,114], and anomalies in the microbiome [115,116]. There is a widespread reduction in brain volume, which is possibly secondary to reduced neurogenesis [117], which may be the most marked in the hippocampus [118] and associated with raised cortisol levels [104]. This broad stress response reduces resilience [119] and may be accompanied by reduced mesolimbic dopamine function, anhedonia, and lack of motivation [120]. Thus, a sizeable proportion of patients could be classified as fulfilling the criteria of treatment-resistant depression.

Treatment-Resistant Depression and other Co-Morbidities as Maintaining Factors: Implications for Treatment

Treatments targeting nutritional recovery are less effective for improving mood [49,50,79,121,122,123]. Therefore, it is possible that strategies used for treatment-resistant depression might be of benefit for people with severe enduring AN. Proof-of-concept studies of neuromodulation such as deep brain stimulation [124] and repetitive transcranial magnetic stimulation have shown potential [125,126,127]. Interestingly, the trajectory of symptom change following these neuromodulation techniques shows differences to that found with more traditional eating disorder treatment, in that an improvement in mood is the main initial effect, whereas improvements in eating disorder psychopathology follow later [125,126,128].
Interest in pharmacological approaches is starting to increase, as summarised in a recent review [129]. There is mixed evidence for the use of antipsychotic medications to treat AN [130], although a recent multicenter outpatient study of olanzapine found small positive effects on agitation and weight gain (albeit with no difference in rates of hospitalisation) [131]. The field may need to consider using drugs that have been shown to have benefit in OCD. For example, high doses of Selective Serotonin Reuptake Inhibitors (SSRIs), exposure, and response treatment are effective for people in the later stages of OCD [132], which has also been recently conceptualized within a staging framework [133]. In addition, there is interest in pharmacological approaches that are being used for treatment-resistant depression, such as ketamine and psilocybin [134]. Interestingly, ketamine showed some promise in a small series of studies in the 1990s [135]. A pilot study of the effects of ketamine on mood and eating disorder cognitions in people with severe and enduring AN is registered on the Australia New Zealand Clinical Trial Registry (anzctr.org.au, ACTRN12618001393246p) and additionally, a psilocybin trial for AN is currently registered (ClinicalTrials.gov, NCT04052568). Therefore, we echo the call by Franko and colleagues [90] to consider using a combined approach to target both mood and eating disorder symptoms, with clear characterization of the patient group.
Although not the topic of this paper, given the similarities between staging models for other psychiatric disorders [8], it may be of interest to look at the other end of the trajectory, the ultra-high risk (UHR) group, and consider whether there might be interventions that could be matched to this stage and provide primary or secondary prevention approaches. The first step is to define the UHR phenotype, which may include traits such as behavioural inhibition, perfectionism, early symptoms of OCD, or social–emotional difficulties.

6. Conclusions

In this latest iteration of the cognitive interpersonal model, we have described treatments targeting modifiable elements. Increasing social connection through encouraging a collaborative inclusive approach towards recovery, by increasing the knowledge and skills of family members, decreases the need for high-intensity care (day or inpatient) and reduces carer burden and patient isolation [49,50,51,136]. Treatment using MANTRA focuses on both inter and intrapersonal model elements [55,56]. Augmenting treatment through digital technology is showing potential [137]. Finally, we are borrowing approaches that show promise in other domains of psychiatry in which a chronic stress response has led to the illness having a life of its own. Neuromodulation techniques are encouraging, and new pharmacological approaches are in progress. Services may need to implement broader clinical assessment skills to more accurately stage the illness to personalise treatments to match patient’s needs and preferences.
However, it is too early for this model to be ossified. The field of eating disorders has been starved of resources for research, and so the evidence is limited. Nevertheless, we think that by using this framework in order to identify targets and by using high-quality randomised controlled trials, we will be able to develop more effective treatments through an iterative process.

Author Contributions

Conceptualization, J.T.; writing—original draft preparation, J.T. and D.W.; writing and editing, J.T. and D.W.; reviewing manuscript, S.A., D.C.B., V.C., K.R. and U.S. All authors have read and agreed to the published version of the manuscript.

Funding

This manuscript was funded through the NIHR -HTA program (project reference number 14/68/09).

Acknowledgments

VC, JT and US acknowledge financial support from the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King’s College London. US is supported by an NIHR Senior Investigator Award.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Craig, P.; Dieppe, P.; Macintyre, S.; Michie, S.; Nazareth, I.; Petticrew, M. Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ 2008, 337, a1655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Schmidt, U.; Treasure, J. Anorexia nervosa: Valued and visible. A cognitive-interpersonal maintenance model and its implications for research and practice. Br. J. Clin. Psychol. 2006, 45, 343–366. [Google Scholar] [CrossRef] [PubMed]
  3. Treasure, J.; Schmidt, U. The cognitive-interpersonal maintenance model of anorexia nervosa revisited: A summary of the evidence for cognitive, socio-emotional and interpersonal predisposing and perpetuating factors. J. Eat. Disord. 2013, 1, 13. [Google Scholar] [CrossRef] [Green Version]
  4. Farstad, S.M.; McGeown, L.M.; von Ranson, K.M. Eating disorders and personality, 2004–2016: A systematic review and meta-analysis. Clin. Psychol. Rev. 2016, 46, 91–105. [Google Scholar] [CrossRef]
  5. Miller, J.L.; Schmidt, L.A.; Vaillancourt, T.; McDougall, P.; Laliberte, M. Neuroticism and introversion: A risky combination for disordered eating among a non-clinical sample of undergraduate women. Eat. Behav. 2006, 7, 69–78. [Google Scholar] [CrossRef]
  6. Watson, H.J.; Yilmaz, Z.; Thornton, L.M.; Hübel, C.; Coleman, J.R.; Gaspar, H.A.; Medland, S.E. Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa. Nat. Genet. 2019, 51, 1207–1214. [Google Scholar] [CrossRef] [Green Version]
  7. Guisinger, S. Adapted to flee famine: Adding an evolutionary perspective on anorexia nervosa. Psychol. Rev. 2003, 110, 745. [Google Scholar] [CrossRef] [Green Version]
  8. Treasure, J.; Stein, D.; Maguire, S. Has the time come for a staging model to map the course of eating disorders from high risk to severe enduring illness? An examination of the evidence. Early Interv. Psychiatry 2015, 9, 173–184. [Google Scholar] [CrossRef]
  9. Goddard, E.; Treasure, J. Anxiety and social-emotional processing in eating disorders: Examination of family trios. Cogn. Ther. Res. 2013, 37, 890–904. [Google Scholar] [CrossRef]
  10. Rhind, C.; Bonfioli, E.; Hibbs, R.; Goddard, E.; Macdonald, P.; Gowers, S.; Treasure, J. An examination of autism spectrum traits in adolescents with anorexia nervosa and their parents. Mol. Autism 2014, 5, 56. [Google Scholar] [CrossRef] [Green Version]
  11. Nielsen, S.; Anckarsäter, H.; Gillberg, C.; Gillberg, C.; Råstam, M.; Wentz, E. Effects of autism spectrum disorders on outcome in teenage-onset anorexia nervosa evaluated by the Morgan-Russell outcome assessment schedule: A controlled community-based study. Mol. Autism 2015, 6, 14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Kothari, R.; Barona, M.; Treasure, J.O.; Micali, N. Social cognition in children at familial high-risk of developing an eating disorder. Front. Behav. Neurosc. 2015, 9, 208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Johnson, J.G.; Cohen, P.; Kasen, S.; Brook, J.S. Childhood adversities associated with risk for eating disorders or weight problems during adolescence or early adulthood. Am. J. Psychiatry 2002, 159, 394–400. [Google Scholar] [CrossRef] [PubMed]
  14. Jewell, T.; Collyer, H.; Gardner, T.; Tchanturia, K.; Simic, M.; Fonagy, P.; Eisler, I. Attachment and mentalization and their association with child and adolescent eating pathology: A systematic review. Int. J. Eat. Disord. 2016, 49, 354–373. [Google Scholar] [CrossRef]
  15. Cardi, V.; Tchanturia, K.; Treasure, J. Premorbid and illness-related social difficulties in eating disorders: An overview of the literature and treatment developments. Curr. Neuropharmacol. 2018, 16, 1122–1130. [Google Scholar] [CrossRef]
  16. Vartanian, L.R.; Hayward, L.E.; Smyth, J.M.; Paxton, S.J.; Touyz, S.W. Risk and resiliency factors related to body dissatisfaction and disordered eating: The identity disruption model. Int. J. Eat. Disord. 2018, 51, 322–330. [Google Scholar] [CrossRef]
  17. Young, J.E.; Klosko, J.S.; Weishaar, M.E. Schema Therapy: A Practitioner’s Guide; Guilford Press: New York, NY, USA, 2003. [Google Scholar]
  18. Arcelus, J.; Haslam, M.; Farrow, C.; Meyer, C. The role of interpersonal functioning in the maintenance of eating psychopathology: A systematic review and testable model. Clin. Psychol. Rev. 2013, 33, 156–167. [Google Scholar] [CrossRef] [Green Version]
  19. Oldershaw, A.; Lavender, T.; Sallis, H.; Stahl, D.; Schmidt, U. Emotion generation and regulation in anorexia nervosa: A systematic review and meta-analysis of self-report data. Clin. Psychol. Rev. 2015, 39, 83–95. [Google Scholar] [CrossRef]
  20. Engel, S.G.; Wonderlich, S.A.; Crosby, R.D.; Mitchell, J.E.; Crow, S.; Peterson, C.B.; Gordon, K.H. The role of affect in the maintenance of anorexia nervosa: Evidence from a naturalistic assessment of momentary behaviors and emotion. J. Abnorm. Psychol. 2013, 122, 709. [Google Scholar] [CrossRef] [Green Version]
  21. Rapee, R.M.; Oar, E.L.; Johnco, C.J.; Forbes, M.K.; Fardouly, J.; Magson, N.R.; Richardson, C.E. Adolescent development and risk for the onset of social-emotional disorders: A review and conceptual model. Behav. Res. Ther. 2019, 123, 103501. [Google Scholar] [CrossRef]
  22. Caglar-Nazali, H.P.; Corfield, F.; Cardi, V.; Ambwani, S.; Leppanen, J.; Olabintan, O.; Micali, N. A systematic review and meta-analysis of ‘Systems for Social Processes’ in eating disorders. Neurosci. Biobehav. Rev. 2014, 42, 55–92. [Google Scholar] [CrossRef] [PubMed]
  23. Cardi, V.; Corfield, F.; Leppanen, J.; Rhind, C.; Deriziotis, S.; Hadjimichalis, A.; Treasure, J. Emotional processing, recognition, empathy and evoked facial expression in eating disorders: An experimental study to map deficits in social cognition. PLoS ONE 2015, 10, e0133827. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Davies, H.; Wolz, I.; Leppanen, J.; Fernandez-Aranda, F.; Schmidt, U.; Tchanturia, K. Facial expression to emotional stimuli in non-psychotic disorders: A systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2016, 64, 252–271. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Oldershaw, A.; DeJong, H.; Hambrook, D.; Schmidt, U. Social attribution in anorexia nervosa. Eur. Eat. Disord. Rev. 2018, 26, 197–206. [Google Scholar] [CrossRef]
  26. Cardi, V.; Di Matteo, R.; Corfield, F.; Treasure, J. Social reward and rejection sensitivity in eating disorders: An investigation of attentional bias and early experiences. World J. Biol. Psychiatry 2013, 14, 622–633. [Google Scholar] [CrossRef]
  27. Cardi, V.; Di Matteo, R.; Gilbert, P.; Treasure, J. Rank perception and self-evaluation in eating disorders. Int. J. Eat. Disord. 2014, 47, 543–552. [Google Scholar] [CrossRef]
  28. Ambwani, S.; Berenson, K.R.; Simms, L.; Li, A.; Corfield, F.; Treasure, J. Seeing things differently: An experimental investigation of social cognition and interpersonal behavior in anorexia nervosa. Int. J. Eat. Disord. 2016, 49, 499–506. [Google Scholar] [CrossRef]
  29. Szczurek, L.; Monin, B.; Gross, J.J. The Stranger Effect: The Rejection of Affective Deviants. Psychol. Sci. 2012, 23, 1105–1111. [Google Scholar] [CrossRef]
  30. Hess, U.; Fischer, A. Emotional Mimicry as Social Regulation. Personal. Soc. Psychol. Rev. 2013, 17, 142–157. [Google Scholar] [CrossRef]
  31. Schneider, K.G.; Hempel, R.J.; Lynch, T.R. That “poker face” just might lose you the game! the impact of expressive suppression and mimicry on sensitivity to facial expressions of emotion. Emotion 2013, 13, 852–866. [Google Scholar] [CrossRef]
  32. McKnight, R.; Boughton, N. Anorexia Nervosa. Br. Med. J. 2014, 22, 1–9. [Google Scholar] [CrossRef] [PubMed]
  33. Hjern, A.; Lindberg, L.; Lindblad, F. Outcome and prognostic factors for adolescent female in-patients with anorexia nervosa: 9-to 4-year follow-up. Br. J. Psychiatry 2006, 189, 428–432. [Google Scholar] [CrossRef] [PubMed]
  34. Treasure, J.; Crane, A.; McKnight, R.; Buchanan, E.; Wolfe, M. First do no harm: Iatrogenic maintaining factors in anorexia nervosa. Eur. Eat. Disord. Rev. 2011, 19, 296–302. [Google Scholar] [CrossRef] [PubMed]
  35. Anastasiadou, D.; Medina-Pradas, C.; Sepulveda, A.R.; Treasure, J. A systematic review of family caregiving in eating disorders. Eat. Behav. 2014, 15, 464–477. [Google Scholar] [CrossRef]
  36. Konstantakopoulos, G.; Tchanturia, K.; Surguladze, S.A.; David, A.S. Insight in eating disorders: Clinical and cognitive correlates. Psychol. Med. 2011, 41, 1951–1961. [Google Scholar] [CrossRef]
  37. Gorwood, P.; Duriez, P.; Lengvenyte, A.; Guillaume, S.; Criquillion, S. Clinical insight in anorexia nervosa: Associated and predictive factors. Psychiatry Res. 2019, 281, 112561. [Google Scholar] [CrossRef]
  38. Treasure, J.; Schmidt, U.; Macdonald, P. (Eds.) The Clinician’s Guide to Collaborative Caring in Eating Disorders: The New Maudsley Method; Routledge: London, UK, 2009. [Google Scholar]
  39. Treasure, J.; Smith, G.; Crane, A. Skills-Based Caring for a Loved One With an Eating Disorder: The New Maudsley Method; Routledge: London, UK, 2016. [Google Scholar]
  40. Sepulveda, A.R.; Kyriacou, O.; Treasure, J. Development and validation of the accommodation and enabling scale for eating disorders (AESED) for caregivers in eating disorders. BMC Health Serv. Res. 2009, 9, 171. [Google Scholar] [CrossRef] [Green Version]
  41. Salerno, L.; Rhind, C.; Hibbs, R.; Micali, N.; Schmidt, U.; Gowers, S.; Treasure, J. An examination of the impact of care giving styles (accommodation and skilful communication and support) on the one year outcome of adolescent anorexia nervosa: Testing the assumptions of the cognitive interpersonal model in anorexia nervosa. J. Affect. Disord. 2016, 191, 230–236. [Google Scholar] [CrossRef]
  42. Dimitropoulos, G.; Klopfer, K.; Lazar, L.; Schacter, R. Caring for a sibling with anorexia nervosa: A qualitative study. Eur. Eat. Disord. Rev. Prof. J. Eat. Disord. Assoc. 2009, 17, 350–365. [Google Scholar] [CrossRef]
  43. Dimitropoulos, G.; Freeman, V.E.; Bellai, K.; Olmsted, M. Inpatients with severe anorexia nervosa and their siblings: Non-shared experiences and family functioning. Eur. Eat. Disord. Rev. 2013, 21, 284–293. [Google Scholar] [CrossRef]
  44. House of Commons Health Committee. Suicide Prevention: Interim Report. Fourth Report of Session; House of Commons: London, UK, 2016.
  45. Treasure, J.; Nazar, B.P. Interventions for the carers of patients with eating disorders. Curr. Psychiatry Rep. 2016, 18, 16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Langley, J.; Treasure, J.; Todd, G. Caring for a Loved One with an Eating Disorder: The New Maudsley Skills-Based Training Manual; Routledge: London, UK, 2018. [Google Scholar]
  47. Treasure, J.; Murphy, T.; Szmukler, T.; Todd, G.; Gavan, K.; Joyce, J. The experience of caregiving for severe mental illness: A comparison between anorexia nervosa and psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 2001, 36, 343–347. [Google Scholar] [CrossRef]
  48. Magill, N.; Rhind, C.; Hibbs, R.; Goddard, E.; Macdonald, P.; Arcelus, J.; Treasure, J. Two-year follow-up of a pragmatic randomised controlled trial examining the effect of adding a carer’s skill training intervention in inpatients with anorexia nervosa. Eur. Eat. Disord. Rev. 2016, 24, 122–130. [Google Scholar] [CrossRef] [PubMed]
  49. Hibbs, R.; Magill, N.; Goddard, E.; Rhind, C.; Raenker, S.; Macdonald, P.; Schmidt, U. Clinical effectiveness of a skills training intervention for caregivers in improving patient and caregiver health following in-patient treatment for severe anorexia nervosa: Pragmatic randomised controlled trial. BJPsych Open 2015, 1, 56–66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Hodsoll, J.; Rhind, C.; Micali, N.; Hibbs, R.; Goddard, E.; Nazar, B.P.; Landau, S. A pilot, multicentre pragmatic randomised trial to explore the impact of carer skills training on carer and patient behaviours: Testing the cognitive interpersonal model in adolescent anorexia nervosa. Eur. Eat. Disord. Rev. 2017, 25, 551–561. [Google Scholar] [CrossRef]
  51. Adamson, J.; Cardi, V.; Kan, C.; Harrison, A.; Macdonald, P.; Treasure, J. Evaluation of a novel transition support intervention in an adult eating disorders service: ECHOMANTRA. Int. Rev. Psychiatry 2019, 31, 382–390. [Google Scholar] [CrossRef]
  52. Pépin, G.; King, R. Collaborative care skills training workshops: Helping carers cope with eating disorders from the UK to Australia. Soc. Psychiatry Psychiatr. Epidemiol. 2013, 48, 805–812. [Google Scholar] [CrossRef]
  53. Quiles, M.Y.; Quiles, S.M.; Escolano, H.M.; Sanmartín, R.; Treasure, J. Testing carer skill training programs in Spanish carers of patients with eating disorders. Psicothema 2018, 30, 295. [Google Scholar]
  54. Schmidt, U.; Wade, T.D.; Treasure, J. The Maudsley Model of Anorexia Nervosa Treatment for Adults (MANTRA): Development, key features, and preliminary evidence. J. Cog. Psychother. 2014, 28, 48–71. [Google Scholar] [CrossRef]
  55. Schmidt, U.; Startup, H.; Treasure, J. A Cognitive-Interpersonal Therapy Workbook for Treating Anorexia Nervosa: The Maudsley Model; Routledge: London, UK, 2018. [Google Scholar]
  56. Walsh, B.T. The enigmatic persistence of anorexia nervosa. Am. J. Psychiatry 2013, 170, 477–484. [Google Scholar] [CrossRef] [Green Version]
  57. Steinglass, J.E.; Walsh, B.T. Neurobiological model of the persistence of anorexia nervosa. J. Eat. Disord. 2016, 4, 19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Uniacke, B.; Walsh, B.T.; Foerde, K.; Steinglass, J. The role of habits in anorexia nervosa: Where we are and where to go from here? Curr. Psychiatry Rep. 2018, 20, 61. [Google Scholar] [CrossRef] [PubMed]
  59. Steinglass, J.E.; Berner, L.A.; Attia, E. Cognitive neuroscience of eating disorders. Psychiatr. Clin. 2019, 42, 75–91. [Google Scholar] [CrossRef] [PubMed]
  60. Steinglass, J.E.; Glasofer, D.R.; Walsh, E.; Guzman, G.; Peterson, C.B.; Walsh, B.T.; Wonderlich, S.A. Targeting habits in anorexia nervosa: A proof-of-concept randomized trial. Psychol. Med. 2018, 48, 2584–2591. [Google Scholar] [CrossRef]
  61. Levinson, C.A.; Brosof, L.C.; Ma, J.; Fewell, L.; Lenze, E.J. Fear of food prospectively predicts drive for thinness in an eating disorder sample recently discharged from intensive treatment. Eat. Behav. 2017, 27, 45–51. [Google Scholar] [CrossRef]
  62. Lambert, E.; Purves, K.; McGregor, T.; Treasure, J.; Cardi, V. Fear conditioning in women with a lifetime diagnosis of anorexia nervosa and healthy controls. In Preparation.
  63. Cardi, V.; Leppanen, J.; Mataix-Cols, D.; Campbell, I.C.; Treasure, J. A case series to investigate food-related fear learning and extinction using in vivo food exposure in anorexia nervosa: A clinical application of the inhibitory learning framework. Eur. Eat. Disord. Rev. 2019, 27, 173–181. [Google Scholar] [CrossRef] [Green Version]
  64. Ramjan, L.M. Nurses and the ‘therapeutic relationship’: Caring for adolescents with anorexia nervosa. J. Adv. Nurs. 2004, 45, 495–503. [Google Scholar] [CrossRef]
  65. Kimber, M.; McTavish, J.R.; Couturier, J.; Le Grange, D.; Lock, J.; MacMillan, H.L. Identifying and responding to child maltreatment when delivering family-based treatment—A qualitative study. Int. J. Eat. Disord. 2019, 52, 292–298. [Google Scholar] [CrossRef]
  66. Den, M.L.; Graham, B.M.; Newall, C.; Richardson, R. Teens that fear screams: A comparison of fear conditioning, extinction, and reinstatement in adolescents and adults. Dev. Psychobiol. 2015, 57, 818–832. [Google Scholar] [CrossRef]
  67. Koskina, A.; Campbell, I.C.; Schmidt, U. Exposure therapy in eating disorders revisited. Neurosci. Biobehav. Rev. 2013, 37, 193–208. [Google Scholar] [CrossRef]
  68. Murray, S.B.; Treanor, M.; Liao, B.; Loeb, K.L.; Griffiths, S.; Le Grange, D. Extinction theory & anorexia nervosa: Deepening therapeutic mechanisms. Behav. Res. Ther. 2016, 87, 1–10. [Google Scholar] [PubMed]
  69. Cardi, V.; Esposito, M.; Clarke, A.; Schifano, S.; Treasure, J. The impact of induced positive mood on symptomatic behaviour in eating disorders. An experimental, AB/BA crossover design testing a multimodal presentation during a test-meal. Appetite 2015, 87, 192–198. [Google Scholar] [CrossRef] [PubMed]
  70. Steinglass, J.; Sysko, R.; Schebendach, J.; Broft, A.; Strober, M.; Walsh, B.T. The application of exposure therapy and D-cycloserine to the treatment of anorexia nervosa: A preliminary trial. J. Psychiatr. Pract. 2007, 13, 238. [Google Scholar] [CrossRef] [Green Version]
  71. Levinson, C.A.; Rodebaugh, T.L.; Fewell, L.; Kass, A.E.; Riley, E.N.; Stark, L.; Lenze, E.J. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: A pilot randomized controlled trial. J. Clin. Psychiatry 2015, 76, e787. [Google Scholar] [CrossRef]
  72. Cardi, V.; Krug, I.; Perpiñá, C.; Mataix-Cols, D.; Roncero, M.; Treasure, J. The use of a nonimmersive virtual reality programme in anorexia nervosa: A single case-report. Eur. Eat. Disord. Rev. 2012, 20, 240–245. [Google Scholar] [CrossRef]
  73. Tchanturia, K.; Davies, H.; Reeder, C.; Wykes, T. Cognitive Remediation Therapy for AN Therapist Manual. 2010. Available online: http://www.katetchanturia.com/publications/c1y51 (accessed on 26 February 2020).
  74. Cardi, V.; Esposito, M.; Bird, G.; Rhind, C.; Yiend, J.; Schifano, S.; Treasure, J. A preliminary investigation of a novel training to target cognitive biases towards negative social stimuli in Anorexia Nervosa. J. Affect. Disord. 2015, 188, 188–193. [Google Scholar] [CrossRef]
  75. Turton, R.; Nazar, B.P.; Burgess, E.E.; Lawrence, N.S.; Cardi, V.; Treasure, J.; Hirsch, C.R. To go or not to go: A proof of concept study testing food-specific inhibition training for women with eating and weight disorders. Eur. Eat. Disord. Rev. 2018, 26, 11–21. [Google Scholar] [CrossRef] [Green Version]
  76. Werthmann, J.; Simic, M.; Konstantellou, A.; Mansfield, P.; Mercado, D.; van Ens, W.; Schmidt, U. Same, same but different: Attention bias for food cues in adults and adolescents with anorexia nervosa. Int. J. Eat. Disord. 2019, 52, 681–690. [Google Scholar] [CrossRef] [Green Version]
  77. Mercado, D.; Schmidt, U.; O’Daly, O.; Campbell, I.; Werthmann, J. Food related attention bias modification training for anorexia nervosa and its potential underpinning mechanisms. J. Eat. Disord. 2020, 8, 1. [Google Scholar] [CrossRef]
  78. Wildes, J.E.; Marcus, M.D.; Bright, A.C.; Dapelo, M.M. Emotion and eating disorder symptoms in patients with anorexia nervosa: An experimental study. Int. J. Eat. Disord. 2012, 45, 876–882. [Google Scholar] [CrossRef] [Green Version]
  79. Rodgers, R.F.; Paxton, S.J. The impact of indicated prevention and early intervention on co-morbid eating disorder and depressive symptoms: A systematic review. J. Eat. Disord. 2014, 2, 30. [Google Scholar] [CrossRef] [PubMed]
  80. Molendijk, M.L.; Hoek, H.W.; Brewerton, T.D.; Elzinga, B.M. Childhood maltreatment and eating disorder pathology: A systematic review and dose-response meta-analysis. Psychol. Med. 2017, 47, 1402–1416. [Google Scholar] [CrossRef] [PubMed]
  81. Monteleone, A.M.; Mereu, A.; Cascino, G.; Criscuolo, M.; Castiglioni, M.C.; Pellegrino, F.; Zanna, V. Re-conceptualization of anorexia nervosa psychopathology: A network analysis study in adolescents with short duration of the illness. Int. J. Eat. Disord. 2019, 52, 1263–1273. [Google Scholar] [CrossRef] [PubMed]
  82. Sauro, C.L.; Ravaldi, C.; Cabras, P.L.; Faravelli, C.; Ricca, V. Stress, hypothalamic-pituitary-adrenal axis and eating disorders. Neuropsychobiology 2008, 57, 95–115. [Google Scholar] [CrossRef] [PubMed]
  83. Chua, Y.W.; Lewis, G.; Easter, A.; Lewis, G.; Solmi, F. Eighteen-year trajectories of depressive symptoms in mothers with a lifetime eating disorder: Findings from the ALSPAC cohort. Br. J. Psychiatry 2019, 14, 1–7. [Google Scholar] [CrossRef]
  84. Tomba, E.; Tecuta, L.; Crocetti, E.; Squarcio, F.; Tomei, G. Residual eating disorder symptoms and clinical features in remitted and recovered eating disorder patients: A systematic review with meta-analysis. Int. J. Eat. Disord. 2019, 52, 759–776. [Google Scholar] [CrossRef] [Green Version]
  85. Godart, N.; Radon, L.; Curt, F.; Duclos, J.; Perdereau, F.; Lang, F.; Corcos, M. Mood disorders in eating disorder patients: Prevalence and chronology of ONSET. J. Affect. Disord. 2015, 185, 115–122. [Google Scholar] [CrossRef]
  86. Dobrescu, S.R.; Dinkler, L.; Gillberg, C.; Råstam, M.; Gillberg, C.; Wentz, E. Anorexia nervosa: 30-year outcome. Br. J. Psychiatry 2019, 22, 1–8. [Google Scholar] [CrossRef] [Green Version]
  87. Solmi, M.; Collantoni, E.; Meneguzzo, P.; Tenconi, E.; Favaro, A. Network analysis of specific psychopathology and psychiatric symptoms in patients with anorexia nervosa. Eur. Eat. Disord. Rev. 2019, 27, 24–33. [Google Scholar] [CrossRef] [Green Version]
  88. Voderholzer, U.; Hessler-Kaufmann, J.B.; Lustig, L.; Läge, D. Comparing severity and qualitative facets of depression between eating disorders and depressive disorders: Analysis of routine data. J. Affect. Disord. 2019, 257, 758–764. [Google Scholar] [CrossRef]
  89. Keski-Rahkonen, A.; Raevuori, A.; Bulik, C.M.; Hoek, H.W.; Rissanen, A.; Kaprio, J. Factors associated with recovery from anorexia nervosa: A population-based study. Int. J. Eat. Disord. 2014, 47, 117–123. [Google Scholar] [CrossRef] [PubMed]
  90. Franko, D.L.; Tabri, N.; Keshaviah, A.; Murray, H.B.; Herzog, D.B.; Thomas, J.J.; Eddy, K.T. Predictors of long-term recovery in anorexia nervosa and bulimia nervosa: Data from a 22-year longitudinal study. J. Psychiatr. Res. 2018, 96, 183–188. [Google Scholar] [CrossRef] [PubMed]
  91. Duncan, T.K.; Sebar, B.; Lee, J. Reclamation of power and self: A meta-synthesis exploring the process of recovery from anorexia nervosa. Adv. Eat. Disord. Theory Res. Pract. 2015, 3, 177–190. [Google Scholar] [CrossRef]
  92. de Vos, J.A.; LaMarre, A.; Radstaak, M.; Bijkerk, C.A.; Bohlmeijer, E.T.; Westerhof, G.J. Identifying fundamental criteria for eating disorder recovery: A systematic review and qualitative meta-analysis. J. Eat. Disord. 2017, 5, 34. [Google Scholar] [CrossRef]
  93. Measelle, J.R.; Stice, E.; Hogansen, J.M. Developmental trajectories of co-occurring depressive, eating, antisocial, and substance abuse problems in female adolescents. J. Abnorm. Psychol. 2006, 115, 524. [Google Scholar] [CrossRef] [Green Version]
  94. Degortes, D.; Zanetti, T.; Tenconi, E.; Santonastaso, P.; Favaro, A. Childhood obsessive–compulsive traits in anorexia nervosa patients, their unaffected sisters and healthy controls: A retrospective study. Eur. Eat. Disord. Rev. 2014, 22, 237–242. [Google Scholar] [CrossRef]
  95. Lilenfeld, L.R.; Kaye, W.H.; Greeno, C.G.; Merikangas, K.R.; Plotnicov, K.; Pollice, C.; Nagy, L. A controlled family study of anorexia nervosa and bulimia nervosa: Psychiatric disorders in first-degree relatives and effects of proband comorbidity. Arch. Gen. Psychiatry 1998, 55, 603–610. [Google Scholar] [CrossRef] [Green Version]
  96. Cederlöf, M.; Thornton, L.M.; Baker, J.; Lichtenstein, P.; Larsson, H.; Rück, C.; Mataix-Cols, D. Etiological overlap between obsessive-compulsive disorder and anorexia nervosa: A longitudinal cohort, multigenerational family and twin study. World Psychiatry 2015, 14, 333–338. [Google Scholar] [CrossRef] [Green Version]
  97. Yilmaz, Z.; Halvorsen, M.; Bryois, J.; Yu, D.; Thornton, L.M.; Zerwas, S.; Erdman, L. Examination of the shared genetic basis of anorexia nervosa and obsessive–compulsive disorder. Mol. Psychiatry 2018. [Google Scholar] [CrossRef] [Green Version]
  98. Forrest, L.N.; Jones, P.J.; Ortiz, S.N.; Smith, A.R. Core psychopathology in anorexia nervosa and bulimia nervosa: A network analysis. Int. J. Eat. Disord. 2018, 51, 668–679. [Google Scholar] [CrossRef]
  99. Montigny, C.; Castellanos-Ryan, N.; Whelan, R.; Banaschewski, T.; Barker, G.J.; Büchel, C.; Nees, F. A phenotypic structure and neural correlates of compulsive behaviors in adolescents. PLoS ONE 2013, 8, e80151. [Google Scholar] [CrossRef] [PubMed]
  100. Fonville, L.; Giampietro, V.; Williams, S.C.R.; Simmons, A.; Tchanturia, K. Alterations in brain structure in adults with anorexia nervosa and the impact of illness duration. Psychol. Med. 2014, 44, 1965–1975. [Google Scholar] [CrossRef] [Green Version]
  101. Connan, F.; Treasure, J. Stress, eating and neurobiology. In Neurobiology in the Treatment of Eating Disorders; Wiley: Chichester, UK, 1998; pp. 211–236. [Google Scholar]
  102. Myrvang, A.D.; Vangberg, T.R.; Stedal, K.; Rø, Ø.; Endestad, T.; Rosenvinge, J.H.; Aslaksen, P.M. Hippocampal subfields in adolescent anorexia nervosa. Psychiatry Res. Neuroimaging 2018, 282, 24–30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Nickel, K.; Joos, A.; Tebartz van Elst, L.; Matthis, J.; Holovics, L.; Endres, D.; Maier, S. Recovery of cortical volume and thickness after remission from acute anorexia nervosa. Int. J. Eat. Disord. 2018, 51, 1056–1069. [Google Scholar] [CrossRef]
  104. Chui, H.T.; Christensen, B.K.; Zipursky, R.B.; Richards, B.A.; Hanratty, M.K.; Kabani, N.J.; Katzman, D.K. Cognitive function and brain structure in females with a history of adolescent-onset anorexia nervosa. Paediatrics 2008, 122, e426–e437. [Google Scholar] [CrossRef] [PubMed]
  105. Fladung, A.K.; Grön, G.; Grammer, K.; Herrnberger, B.; Schilly, E.; Grasteit, S.; von Wietersheim, J. A neural signature of anorexia nervosa in the ventral striatal reward system. Am. J. Psychiatry 2009, 167, 206–212. [Google Scholar] [CrossRef]
  106. Fladung, A.K.; Schulze, U.M.E.; Schöll, F.; Bauer, K.; Grön, G. Role of the ventral striatum in developing anorexia nervosa. Transl. Psychiatry 2013, 3, e315. [Google Scholar] [CrossRef] [Green Version]
  107. Chami, R.; Treasure, J. The Neurobiology of Trauma and Eating Disorders. Trauma-Informed Approaches to Eating Disorders; Springer Publishing Company: New York, NY, USA, 2018. [Google Scholar]
  108. Akil, H.; Gordon, J.; Hen, R.; Javitch, J.; Mayberg, H.; McEwen, B.; Nestler, E.J. Treatment resistant depression: A multi-scale, systems biology approach. Neurosci. Biobehav. Rev. 2018, 84, 272–288. [Google Scholar] [CrossRef]
  109. Teicher, M.H.; Samson, J.A. Childhood maltreatment and psychopathology: A case for ecophenotypic variants as clinically and neurobiologically distinct subtypes. Am. J. Psychiatry 2013, 170, 1114–1133. [Google Scholar] [CrossRef]
  110. Putignano, P.; Dubini, A.; Toja, P.; Invitti, C.; Bonfanti, S.; Redaelli, G.; Cavagnini, F. Salivary cortisol measurement in normal-weight, obese and anorexic women: Comparison with plasma cortisol. Eur. J. Endocrinol. 2001, 145, 165–171. [Google Scholar] [CrossRef] [Green Version]
  111. Misra, M.; Klibanski, A. Endocrine consequences of anorexia nervosa. Lancet Diabetes Endocrinol. 2014, 2, 581–592. [Google Scholar] [CrossRef] [Green Version]
  112. Chami, R.; Monteleone, A.M.; Treasure, J.; Monteleone, P. Stress hormones and eating disorders. Mol. Cell. Endocrinol. 2018, 497, 110349. [Google Scholar] [CrossRef] [PubMed]
  113. Dalton, B.; Campbell, I.; Chung, R.; Breen, G.; Schmidt, U.; Himmerich, H. Inflammatory Markers in Anorexia Nervosa: An Exploratory Study. Nutrients 2018, 10, 1573. [Google Scholar] [CrossRef] [Green Version]
  114. Dalton, B.; Leppanen, J.; Campbell, I.C.; Chung, R.; Breen, G.; Schmidt, U.; Himmerich, H. A longitudinal analysis of cytokines in anorexia nervosa. Brain Behav. Immun. 2019. [Google Scholar] [CrossRef]
  115. Herpertz-Dahlmann, B.; Seitz, J.; Baines, J. Food matters: How the microbiome and gut–brain interaction might impact the development and course of anorexia nervosa. Eur. Child Adolesc. Psychiatry 2017, 26, 1031–1041. [Google Scholar] [CrossRef] [Green Version]
  116. Seitz, J.; Trinh, S.; Herpertz-Dahlmann, B. The microbiome and eating disorders. Psychiatr. Clin. 2019, 42, 93–103. [Google Scholar] [CrossRef]
  117. Barona, M.; Brown, M.; Clark, C.; Frangou, S.; White, T.; Micali, N. White matter alterations in anorexia nervosa: Evidence from a voxel-based meta-analysis. Neurosc. Biobehav. Rev. 2019, 100, 285–295. [Google Scholar] [CrossRef]
  118. Connan, F.; Murphy, F.; Connor, S.E.; Rich, P.; Murphy, T.; Bara-Carill, N.; Morris, R.G. Hippocampal volume and cognitive function in anorexia nervosa. Psychiatry Res. Neuroimaging 2006, 146, 117–125. [Google Scholar] [CrossRef]
  119. Cathomas, F.; Murrough, J.W.; Nestler, E.J.; Han, M.H.; Russo, S.J. Neurobiology of resilience: Interface between mind and body. Biol. Psychiatry 2019, 86, 410–420. [Google Scholar] [CrossRef]
  120. Collo, G.; Pich, E.M. A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: Focus on dopaminergic system. Neural Regen. Res. 2020, 15, 1027. [Google Scholar] [CrossRef]
  121. Schmidt, U.; Oldershaw, A.; Jichi, F.; Sternheim, L.; Startup, H.; McIntosh, V.; Landau, S. Out-patient psychological therapies for adults with anorexia nervosa: Randomised controlled trial. Br. J. Psychiatry 2012, 201, 392–399. [Google Scholar] [CrossRef] [Green Version]
  122. Albano, G.; Hodsoll, J.; Kan, C.; Lo Coco, G.; Cardi, V. Task-sharing interventions for patients with anorexia nervosa or their carers: A systematic evaluation of the literature and meta-analysis of outcomes. Int. Rev. Psychiatry 2019, 31, 367–381. [Google Scholar] [CrossRef] [PubMed]
  123. Schmidt, U.; Magill, N.; Renwick, B.; Keyes, A.; Kenyon, M.; Dejong, H.; Watson, C. The Maudsley Outpatient Study of Treatments for Anorexia Nervosa and Related Conditions (MOSAIC): Comparison of the Maudsley Model of Anorexia Nervosa Treatment for Adults (MANTRA) with specialist supportive clinical management (SSCM) in outpatients with broadly defined anorexia nervosa: A randomized controlled trial. J. Consult. Clin. Psychol. 2015, 83, 796. [Google Scholar] [PubMed]
  124. Lipsman, N.; Woodside, D.B.; Giacobbe, P.; Hamani, C.; Carter, J.C.; Norwood, S.J.; Smith, G.S. Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: A phase 1 pilot trial. Lancet 2013, 381, 1361–1370. [Google Scholar] [CrossRef]
  125. McClelland, J.; Kekic, M.; Bozhilova, N.; Nestler, S.; Dew, T.; Van den Eynde, F.; Schmidt, U. A randomised controlled trial of neuronavigated repetitive transcranial magnetic stimulation (rTMS) in anorexia nervosa. PLoS ONE 2016, 11, e0148606. [Google Scholar] [CrossRef] [Green Version]
  126. Dalton, B.; Bartholdy, S.; McClelland, J.; Kekic, M.; Rennalls, S.J.; Werthmann, J.; Glennon, D. Randomised controlled feasibility trial of real versus sham repetitive transcranial magnetic stimulation treatment in adults with severe and enduring anorexia nervosa: The TIARA study. BMJ Open 2018, 8, e021531. [Google Scholar] [CrossRef]
  127. Knyahnytska, Y.O.; Blumberger, D.M.; Daskalakis, Z.J.; Zomorrodi, R.; Kaplan, A.S. Insula H-coil deep transcranial magnetic stimulation in severe and enduring anorexia nervosa (SE-AN): A pilot study. Neuropsychiatr. Dis. Treat. 2019, 15, 2247. [Google Scholar] [CrossRef] [Green Version]
  128. Lipsman, N.; Lam, E.; Volpini, M.; Sutandar, K.; Twose, R.; Giacobbe, P.; Lozano, A.M. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. Lancet Psychiatry 2017, 4, 285–294. [Google Scholar] [CrossRef]
  129. Himmerich, H.; Treasure, J. Psychopharmacological advances in eating disorders. Expert Rev. Clin. Pharmacol. 2018, 11, 95–108. [Google Scholar] [CrossRef] [Green Version]
  130. Dold, M.; Aigner, M.; Klabunde, M.; Treasure, J.; Kasper, S. Second-generation antipsychotic drugs in anorexia nervosa: A meta-analysis of randomized controlled trials. Psychother. Psychosom. 2015, 84, 110–116. [Google Scholar] [CrossRef]
  131. Attia, E.; Steinglass, J.E.; Walsh, B.T.; Wang, Y.; Wu, P.; Schreyer, C.; Marcus, M.D. Olanzapine versus placebo in adult outpatients with anorexia nervosa: A randomized clinical trial. Am. J. Psychiatry 2019, 176, 449–456. [Google Scholar] [CrossRef] [PubMed]
  132. Hirschtritt, M.E.; Bloch, M.H.; Mathews, C.A. Obsessive-compulsive disorder: Advances in diagnosis and treatment. JAMA 2017, 317, 1358–1367. [Google Scholar] [CrossRef] [PubMed]
  133. Fontenelle, L.F.; Yücel, M. A Clinical Staging Model for Obsessive–Compulsive Disorder: Is It Ready for Prime Time? EClinicalMedicine 2019, 7, 65–72. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  134. Rucker, J.J.; Iliff, J.; Nutt, D.J. Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology 2018, 142, 200–218. [Google Scholar] [PubMed]
  135. Mills, I.H.; Park, G.R.; Manara, A.R.; Merriman, R.J. Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions. QJM Mon. J. Assoc. Physicians 1998, 91, 493–503. [Google Scholar] [CrossRef] [Green Version]
  136. Cardi, V.; Albano, G.; Ambwani, S.; Cao, L.; Crosby, R.D.; Macdonald, P.; Treasure, J. A randomised clinical trial to evaluate the acceptability and efficacy of an early phase, online, guided augmentation of outpatient care for adults with anorexia nervosa. Psychol. Med. 2019, 16, 1–12. [Google Scholar] [CrossRef] [Green Version]
  137. Cardi, V.; Ambwani, S.; Robinson, E.; Albano, G.; MacDonald, P.; Aya, V.; Arcelus, J. Transition care in anorexia nervosa through guidance online from peer and carer expertise (TRIANGLE): Study protocol for a randomised controlled trial. Eur. Eat. Disord. Rev. 2017, 25, 512–523. [Google Scholar] [CrossRef]
Jcm 09 00630 g001 550
Figure 1. The cognitive–interpersonal maintenance model of anorexia nervosa.
Figure 1. The cognitive–interpersonal maintenance model of anorexia nervosa.
Jcm 09 00630 g001
Jcm 09 00630 g002 550
Figure 2. Severe and enduring anorexia nervosa: a maintenance model.
Figure 2. Severe and enduring anorexia nervosa: a maintenance model.
Jcm 09 00630 g002

Share and Cite

MDPI and ACS Style

Treasure, J.; Willmott, D.; Ambwani, S.; Cardi, V.; Clark Bryan, D.; Rowlands, K.; Schmidt, U. Cognitive Interpersonal Model for Anorexia Nervosa Revisited: The Perpetuating Factors that Contribute to the Development of the Severe and Enduring Illness. J. Clin. Med. 2020, 9, 630. https://doi.org/10.3390/jcm9030630

AMA Style

Treasure J, Willmott D, Ambwani S, Cardi V, Clark Bryan D, Rowlands K, Schmidt U. Cognitive Interpersonal Model for Anorexia Nervosa Revisited: The Perpetuating Factors that Contribute to the Development of the Severe and Enduring Illness. Journal of Clinical Medicine. 2020; 9(3):630. https://doi.org/10.3390/jcm9030630

Chicago/Turabian Style

Treasure, Janet, Daniel Willmott, Suman Ambwani, Valentina Cardi, Danielle Clark Bryan, Katie Rowlands, and Ulrike Schmidt. 2020. "Cognitive Interpersonal Model for Anorexia Nervosa Revisited: The Perpetuating Factors that Contribute to the Development of the Severe and Enduring Illness" Journal of Clinical Medicine 9, no. 3: 630. https://doi.org/10.3390/jcm9030630

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop